| Year | 2017 |
|---|---|
| Authors | Michael Hsiao ,Chien MH, Lee WJ, Chang YC, Chang WM, Lai TC, Chan DV, Sharma R, Lin YF, (Hsiao M)* |
| Paper Title | A Fas ligand (FasL)-fused humanized antibody against tumor-associated glycoprotein 72 (hcc49scFV-FasL) selectively exhibits the cytotoxic effect against oral cancer cells with a low FasL/Fas ratio |
| Journal Title | Molecular Cancer Therapeutics |
| Vol.No | Jun;16(6), 1102-1113 |
| Level Type | SCI |
| Paper Type | 已出版 |
| ISSN(ISBN) | 1535-7163 |
| Reference URL | https://www.ncbi.nlm.nih.gov/pubmed/28292939 |
